STRETCHING IN ANKYLOSING SPONDYLITIS
To evaluate the effects of stretching exercise in patients with ankylosing spondylitis at quality of life, functional capacity in patients with BASDAI lower than 4.Evaluate 40 patients with the diagnose of ankylosing spondylitis according to the criteria of the American College of rheumatology provenient from FMUSP at Clinical Hospital of São Paulo.
|Study Design:||Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Supportive Care
|Official Title:||BENEFITIAL EFFECTS OF A STRETCHING EXERCISE PROGRAM FOR PATIENTS WITH ANKYLOSING SPONDYLITIS - A RANDOMIZED CONTROLLED TRIAL|
- FUNCTIONAL INDEX [ Time Frame: sixteen weeks ] [ Designated as safety issue: Yes ]BASFI - Bath ankylosyng spondylitis functional index
- BASMI [ Time Frame: sixteen weeks ] [ Designated as safety issue: Yes ]Bath ankylosing spondylitis motion index
- patient evaluation quality of life [ Time Frame: sixteen weeks ] [ Designated as safety issue: Yes ]BAS-G, ASQOL, SF 12
- flexibility [ Time Frame: sixteen weeks ] [ Designated as safety issue: Yes ]FINGER TO FLOOR DISTANCE, intermaleolar distance,head lateral rotation , head lateral flexion, chest expansibility, Pavelka toracolumbar rotation.
|Study Start Date:||July 2012|
|Study Completion Date:||June 2013|
|Primary Completion Date:||June 2013 (Final data collection date for primary outcome measure)|
|No Intervention: ankylosing spondylitis control|
Experimental: ankylosing spondylitis
stretching exercises,30 minutes, twice a week.
Other: stretching exercise
30 minutes, twice a week
The evaluation complies BASFI, BASDAI, BASMI,BAS-G, ASQOL, SF 12,MASES, finger to floor distance, intermaleolar distance, lateral rotation of head, lateral flexion of the head, stiffness VAS, chest expasibility, Pavelka evaluation. All patients are allocatted randomly into 2 groups. One control with no exercise or group 1 with stretching exercise ( 30 minutes).
Please refer to this study by its ClinicalTrials.gov identifier: NCT01690273
|University of Sao Paulo|
|Sao Paulo, Brazil, 05403-010|